An Illustration of the Potential Health and Economic Benefits of Combating Antibiotic-Resistant Gonorrhea.

ABSTRACT: Preventing the emergence of ceftriaxone-resistant Neisseria gonorrhoeae can potentially avert hundreds of millions of dollars in direct medical costs of gonorrhea and gonorrhea-attributable HIV infections. In the illustrative scenario we examined, emerging ceftriaxone resistance could lead to 1.2 million additional N. gonorrhoeae infections within 10 years, costing $378.2 million.

SUBMITTER: Chesson HW 

PROVIDER: S-EPMC6724164 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature